Influence of FCGR3A-V158F polymorphism on the therapeutic response to ocrelizumab in patients with Relapsing Multiple SclerosisGianmarco Abbadessa,Giuseppina Miele,Rosaria Benedetti,Ugo Chianese,Elisabetta Signoriello,Rosanna Missione,Giacomo Lus, Simona Bonavita,Lucia AltucciMULTIPLE SCLEROSIS JOURNAL(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要